Plasmid-mediated extended spectrum beta-lactamases
- 30 June 1992
- journal article
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 22, 524-528
- https://doi.org/10.1016/s0399-077x(05)80864-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmidsAntimicrobial Agents and Chemotherapy, 1989
- Plasmid mediated ceftazidime resistance associated with a β-lactamase giving a slow nitrocefin reactionJournal of Antimicrobial Chemotherapy, 1989
- Identification of two novel TEM-derivative ceftazidimases, CAZ-6 and CAZ-7, from Klebsiella pneumonie isolatesJournal of Antimicrobial Chemotherapy, 1989
- SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactamsAntimicrobial Agents and Chemotherapy, 1989
- Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Plasmid-Mediated -Lactamase (TEM-7) Involved in Resistance to Ceftazidime and AztreonamClinical Infectious Diseases, 1988
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988
- Two presumed novel β-lactamases in members of the family EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 1988
- Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporinsInfection, 1987
- Evolution of plasmid-coded resistance to broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1985